Sickle Cell Anemia Advocacy Inc is categorized under Medical Research in Ann Arbor, MI and active since 1999.
Sickle Cell Anemia Advocacy Inc was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Helen Vining at the company’s single location by writing to 4254 Lake Forest Drive East, Ann Arbor, Michigan MI 48108 or by phoning (734) 741-5041. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sickle Cell Anemia Advocacy Inc |
| Contact Person: | Helen Vining |
| Address: | 4254 Lake Forest Drive East, Ann Arbor, Michigan 48108 |
| Phone Number: | (734) 741-5041 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Sickle Cell Anemia Advocacy Inc was started in 1999 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Helen Vining for inquiries that concern Sickle Cell Anemia Advocacy Inc by calling the company number (734) 741-5041, as your correspondence is most welcome. Additionally, the physical location of the single location of Sickle Cell Anemia Advocacy Inc can be found at the coordinates 42.225227,-83.765234 as well as the street address 4254 Lake Forest Drive East in Ann Arbor, Michigan 48108.
For its online presence, you may visit Sickle Cell Anemia Advocacy Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.